Anolitum neutralium ANK (Solution) Instructions for Use
Marketing Authorization Holder
Ekran NPO, PJSC (Russia)
ATC Code
D08AX (Other antiseptics and disinfectants)
Dosage Form
| Anolitum neutralium ANK | Solution for topical and external application: 400 ml or 450 ml fl. |
Dosage Form, Packaging, and Composition
Solution for topical and external application transparent, colorless, with a slight smell of chlorine.
| 1 ml | |
| Hydroperoxide oxidants | 0.08-0.12 mg |
Excipients : sodium chloride solution 22 %.
400 ml – bottles.
450 ml – bottles.
Clinical-Pharmacological Group
Antiseptic for external and topical use
Pharmacotherapeutic Group
Antiseptic
Pharmacological Action
Anolitum neutralium ANK is an aqueous solution of a diluted sodium chloride solution passed through an electrochemical reactor that produces chlorine-oxygen and hydroperoxide oxidants (hypochlorous acid, hypochlorite ion, active oxygen compounds).
Anolitum neutralium ANK is non-toxic, has high reactivity and catalytic activity at low concentrations of active substances, disinfecting activity, cleansing and anti-inflammatory properties.
Anolitum neutralium ANK accelerates the healing of infected purulent wounds.
Pharmacokinetics
The active substances of Anolitum neutralium ANK do not have a resorptive effect on the body when applied externally or topically.
Indications
- Treatment of the skin, skin folds, mucous membranes for the purpose of disinfection and removal of organic contaminants (sweat, sebaceous gland secretions, other contaminants);
- Treatment of infected wounds, prevention of wound infection.
ICD codes
| ICD-10 code | Indication |
| T79.3 | Posttraumatic wound infection, not elsewhere classified |
| Z51.4 | Preparatory procedures for subsequent treatment or examination, not elsewhere classified |
| ICD-11 code | Indication |
| NF0A.3 | Posttraumatic wound infection, not elsewhere classified |
| QB9A | Preparatory procedures for subsequent treatment |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Externally. Topically.
The prepared solution is applied to a gauze pad until it is intensively moistened, and the pad soaked in Anolitum neutralium ANK is applied to the treated inflamed or healthy area of the skin.
The application time is 10 -15 minutes. The consumption of Anolitum neutralium ANK during application therapy is 40-70 ml per 1000 cm2 of skin surface, which corresponds to a dose of active substances from 4 to 7 mg – when converted to human body weight, approximately 0.06-0.1 mg/kg of body weight per one application.
After the application, the area of the skin treated with Anolitum neutralium ANK is dried for several minutes, and treatment is continued by other methods at the choice of the attending physician (dry sterile dressing, fat dressings, ointment dressings, or other methods).
The total number of applications with anolyte is 2-3 times a day. The duration of the treatment course is 5-7 days.
Adverse Reactions
Allergic reactions.
If the exposure time is increased to more than 15 minutes, skin irritation may occur.
Contraindications
- Hypersensitivity to the components of the drug;
- Basal cell carcinoma at the site of the intended treatment;
- Skin cancer at the site of the intended treatment.
Special Precautions
The synthesis of the drug in electrochemical units such as STEL ex tempore in the conditions of an operating room, dressing room, procedure room, or at the patient’s bedside is allowed.
The drug prepared ex tempore is placed in clean sterile containers and used according to the indications.
Drug Interactions
Do not use concomitantly with iodine-containing antiseptics
Storage Conditions
Store at a temperature from 15°C (59°F) to 25°C (77°F), in a place protected from light. Freezing or heating of the drug is not allowed.
Shelf Life
The shelf life is 5 days from the date of manufacture of the drug.
Dispensing Status
By prescription.
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer